| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
731,500,000 |
| Market
Cap: |
336.49(M) |
| Last
Volume: |
141,003 |
Avg
Vol: |
140,611 |
| 52
Week Range: |
$0.4199 - $1.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Northwest Biotherapeutics is a biotechnology company focused on developing personalized immune therapies for cancer. Co. has developed a platform technology, DCVax®, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. Co.'s primary product, DCVax®-L, is designed to treat solid tumor cancers in which the tumor can be surgically removed. This product is in a 331-patient Phase III trial for newly diagnosed Glioblastome multiforme. Co.'s second product, DCVax®-Direct, is designed to treat inoperable solid tumors. Co. is working on preparations for Phase II trials of DCVax-Direct in various cancers, when resources permit.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
570,000 |
570,000 |
570,000 |
| Total Sell Value |
$0 |
$469,430 |
$469,430 |
$469,430 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
2 |
2 |
2 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Malik Navid |
Director |
– • – |
2023-11-17 |
4 |
S |
$0.82 |
$365,055 |
D/D |
(445,000) |
0 |
|
37% |
|
| Malik Navid |
Director |
– • – |
2023-11-16 |
4 |
S |
$0.84 |
$104,375 |
D/D |
(125,000) |
445,000 |
|
39% |
|
| Bosch Marnix L |
Chief Technical Officer |
• – – |
2023-04-03 |
4 |
A |
$0.25 |
$29,839 |
D/D |
119,355 |
119,355 |
|
- |
|
| Jasinowski Jerry J |
Director |
– • – |
2022-12-01 |
4 |
A |
$21.25 |
$599,994 |
D/D |
28,235 |
28,235 |
|
- |
|
| Jasinowski Jerry J |
Director |
– • – |
2020-02-03 |
4 |
A |
$0.19 |
$100,000 |
D/D |
526,316 |
1,891,347 |
|
- |
|
| Powers Linda F |
President and CEO |
• • • |
2018-12-28 |
4 |
S |
$0.17 |
$136,705 |
I/I |
(804,146) |
0 |
|
- |
|
| Powers Linda F |
President and CEO |
• • • |
2018-12-27 |
4 |
S |
$0.17 |
$604,969 |
D/D |
(3,558,639) |
29,411,760 |
|
- |
|
| Cf Woodford Equity Income Fund |
10% Owner |
– – • |
2015-11-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,316,679 |
|
- |
|
| Cf Woodford Equity Income Fund |
10% Owner |
– – • |
2015-11-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,915,937 |
|
- |
|
| Cognate Bioservices, Inc. |
10% Owner |
– – • |
2015-06-30 |
4 |
S |
$4.00 |
$7,318,348 |
D/D |
(1,768,092) |
18,460,390 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-09-15 |
4 |
S |
$5.02 |
$750,500 |
D/D |
(149,502) |
20,228,482 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-09-01 |
4 |
B |
$0.00 |
$0 |
D/D |
639,108 |
20,377,984 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-08-27 |
4 |
S |
$5.17 |
$750,002 |
D/D |
(145,068) |
19,738,876 |
|
- |
|
| Farmer Robert A |
Director |
– • – |
2014-08-01 |
4 |
B |
$5.60 |
$16,873 |
I/I |
3,013 |
135,417 |
2.1 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-08-01 |
4 |
B |
$0.00 |
$0 |
D/D |
550,219 |
19,883,944 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-07-01 |
4 |
B |
$0.00 |
$0 |
D/D |
796,879 |
19,333,725 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-06-30 |
4 |
B |
$0.00 |
$0 |
D/D |
562,500 |
18,536,847 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-06-01 |
4 |
B |
$0.00 |
$0 |
D/D |
385,320 |
17,974,347 |
2.37 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
|
0.01 (1.27%) 
